A Case of Complete Resolution of Severe Plantar Dyshidrotic Eczema With Dupilumab

February 2019 | Volume 18 | Issue 2 | Editorials | 211 | Copyright © February 2019


Sonali Nanda MS,a Nicole Nagrani BS,a Flor MacQuhae MD,a Anna Nichols MD PhDa,b

aDepartment of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL bDepartment of Dermatology and Cutaneous Surgery, Sylvester Comprehensive Cancer Center, Miami, FL

DISCLOSURE

The authors have no declared conflicts of interest.

REFERENCES

  1. Wollenberg A, Ariens L, Thurau S, et al. Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment. J Allergy Clin Immunol Pract. 2018.
  2. Lofgren SM, Warshaw EM. Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis. 2006;17(4):165-181.
  3. Abrouk M, Farahnik B, Zhu TH, et al. Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses. J Am Acad Dermatol. 2017;77(1):177-180.
  4. Seegraber M, Srour J, Walter A, et al. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol. 2018;11(5):467-474.
  5. Weston GK, Hooper J, Strober BE. Dupilumab in the Treatment of Dyshidrosis: A Report of Two Cases. J Drugs Dermatol. 2018;17(3):355-356.
  6. Zirwas MJ. Dupilumab for Hand Eczema. J Am Acad Dermatol. 2018

AUTHOR CORRESPONDENCE

Sonali Nanda MS SXN480@miami.edu
Close Menu